Lattice Biologics (TSXV:LBL.H) Total Inventories : C$0.00 Mil (As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Total Inventories?

Lattice Biologics's total inventories for the quarter that ended in Jun. 2021 was C$0.00 Mil. Lattice Biologics's average total inventories from the quarter that ended in Mar. 2021 to the quarter that ended in Jun. 2021 was C$0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Lattice Biologics's Net-Net Working Capital per share for the quarter that ended in Jun. 2021 was C$-0.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lattice Biologics Total Inventories Historical Data

The historical data trend for Lattice Biologics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Total Inventories Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Total Inventories

Get a 7-Day Free Trial

2.88

2.27

1.93

0.93

0.69

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Total Inventories	Get a 7-Day Free Trial															0.79	0.69	0.74	-	-

Lattice Biologics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Lattice Biologics (TSXV:LBL.H) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Lattice Biologics's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2021 is

	Net-Net Working Capital Per Share (Q: Jun. 2021 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0	+	0.75 * 0	+	0.5 * 0	-	0.618
-	0	-	0)	/	128.218
=	-0.00

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lattice Biologics's Days Inventory for the three months ended in Jun. 2021 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2021 )	/	Cost of Goods Sold (Q: Jun. 2021 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lattice Biologics's Inventory Turnover for the quarter that ended in Jun. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2021 )	/	Average Total Inventories (Q: Jun. 2021 )
	=	0	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lattice Biologics's Inventory to Revenue for the quarter that ended in Jun. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2021 )	/	Revenue (Q: Jun. 2021 )
	=	0	/	0
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Lattice Biologics Total Inventories Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines